These results (see Table 2) are in general agreement with the recent findings of Gordan et al. [8] who showed that HIF-2α expression in pVHL- deficient CCRCC tumor lines potentiated c-Myc activity, resulting in enhanced growth and resistance to replication stress. The gene discussed is MYC; the disease is neoplasm.